跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VALOMEL agomelatine (as agomelatine-citric acid) 25 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
VALOMEL agomelatine (as agomelatine-citric acid) 25 mg tablet blister pack
Approved
STANDARD
VALOMEL agomelatine (as agomelatine-citric acid) 25 mg tablet blister pack
Helix Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
8b69d3269ceb8635
Company
Helix Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
8b69d3269ceb8635
Product Name
VALOMEL agomelatine (as agomelatine-citric acid) 25 mg tablet blister pack
Artg Id
381137
Artg Name
VALOMEL agomelatine (as agomelatine-citric acid) 25 mg tablet blister pack
Sponsor
Helix Pharmaceuticals Pty Ltd
Company Detail Path
/organization/helix-pharmaceuticals-pty-ltd
Artg Date
2024-01-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e0dad93598012114f177cf0e8ff69b85.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2bdf58c16d53bc3b10c9f990c0ab6167.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
8b69d3269ceb8635
Type
Standard
Back to TGA Approvals